GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Net Cash per Share

Vita Life Sciences (ASX:VLS) Net Cash per Share : A$0.16 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Vita Life Sciences's Net Cash per Share for the quarter that ended in Dec. 2024 was A$0.16.

The historical rank and industry rank for Vita Life Sciences's Net Cash per Share or its related term are showing as below:

ASX:VLS' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 3.63   Med: 25.83   Max: 135.5
Current: 14.06

During the past 13 years, the highest Price-to-Net-Cash Ratio of Vita Life Sciences was 135.50. The lowest was 3.63. And the median was 25.83.

ASX:VLS's Price-to-Net-Cash is ranked worse than
62.6% of 262 companies
in the Drug Manufacturers industry
Industry Median: 9.38 vs ASX:VLS: 14.06

Vita Life Sciences Net Cash per Share Historical Data

The historical data trend for Vita Life Sciences's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Net Cash per Share Chart

Vita Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 0.01 0.49 0.16

Vita Life Sciences Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.07 0.49 0.15 0.16

Competitive Comparison of Vita Life Sciences's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita Life Sciences's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's Price-to-Net-Cash falls into.


;
;

Vita Life Sciences Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Vita Life Sciences's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as

Net Cash per Share (A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(28.601-19.609--0.071)/56.561
=0.16

Vita Life Sciences's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as

Net Cash per Share (Q: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(28.601-19.609--0.071)/56.561
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita Life Sciences  (ASX:VLS) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Vita Life Sciences Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.

Vita Life Sciences Headlines

No Headlines